Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00361244
Status:
TERMINATED
Last Update Posted:
2017-02-17
First Post:
2006-08-04
Brief Title:
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
Sponsor:
Organization:
Massachusetts General Hospital